# A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

> **NCT01014975** · PHASE1,PHASE2 · COMPLETED · sponsor: **Grifols Therapeutics LLC** · enrollment: 40 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Plasmin (Human)
- **BIOLOGICAL:** Plasmin (Human)
- **BIOLOGICAL:** Plasmin (Human)

## Key facts

- **NCT ID:** NCT01014975
- **Lead sponsor:** Grifols Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2013-11
- **Final completion:** 2014-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014975, "A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01014975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*